Status:
COMPLETED
Cognitive Behavioral Therapy for Treatment of Adult Attention Deficit Hyperactivity Disorder
Lead Sponsor:
Massachusetts General Hospital
Collaborating Sponsors:
National Institute of Mental Health (NIMH)
Conditions:
Attention Deficit Disorder With Hyperactivity
Eligibility:
All Genders
18-65 years
Phase:
NA
Brief Summary
This study will determine the efficacy of cognitive behavioral therapy in treating adults with attention deficit hyperactivity disorder.
Detailed Description
Attention deficit hyperactivity disorder (ADHD), previously believed to be a disorder of childhood, affects as many as 5 percent of adults. Adults with ADHD are at high risk for academic and occupatio...
Eligibility Criteria
Inclusion
- Diagnosis of adult ADHD of at least mild clinical severity (CGI score of 3 or greater)
- Stable on medications for adult ADHD for at least 2 months
- Between 18 and 65 years old
- Be able to give informed consent and comply with study procedures
Exclusion
- Moderate to severe major depression, clinically significant panic disorder (CGI for depression or panic greater than 4), bipolar disorder, organic mental disorders, psychotic disorders, or pervasive developmental disorders
- Active suicidality (HAM-D suicidality item rated 3 or 4)
- Current substance abuse or dependence
- IQ less than 90
- Suicide risk
- Prior participation in cognitive behavioral therapy for ADHD
Key Trial Info
Start Date :
September 1 2004
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 1 2010
Estimated Enrollment :
86 Patients enrolled
Trial Details
Trial ID
NCT00118911
Start Date
September 1 2004
End Date
July 1 2010
Last Update
January 2 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Massachusetts General Hospital
Boston, Massachusetts, United States, 02114